期刊
FREE RADICAL BIOLOGY AND MEDICINE
卷 183, 期 -, 页码 75-88出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.freeradbiomed.2022.03.012
关键词
Nicotinamide riboside; Diabetic cardiomyopathy; Mfn2; Mitochondrial dynamics; Oxidative stress
资金
- National Natural Science Foundation of China [81770369, 82070385, 82070387, 81800229]
- Innovation Project of Tangdu Hospital [2019YXGJ003, 2019GJHZ003]
In patients with diabetes, myocardial dysfunction is associated with an imbalance in mitochondrial fusion/fission dynamics. Nicotinamide riboside (NR) supplementation can ameliorate mitochondrial dysfunction and oxidative stress by promoting mitochondrial fusion. This study suggests that promoting mitochondrial fusion through oral supplementation of NR could be a potential strategy for delaying cardiac complications in patients with diabetes.
Myocardial dysfunction is associated with an imbalance in mitochondrial fusion/fission dynamics in patients with diabetes. However, effective strategies to regulate mitochondrial dynamics in the diabetic heart are still lacking. Nicotinamide riboside (NR) supplementation ameliorated mitochondrial dysfunction and oxidative stress in both cardiovascular and aging-related diseases. This study investigated whether NR protects against diabetes-induced cardiac dysfunction by regulating mitochondrial fusion/fission and further explored the un-derlying mechanisms. Here, we showed an evident decrease in NAD(+) (nicotinamide adenine dinucleotide) levels and mitochondrial fragmentation in the hearts of leptin receptor-deficient diabetic (db/db) mouse models. NR supplementation significantly increased NAD(+) content in the diabetic hearts and promoted mitochondrial fusion by elevating Mfn2 level. Furthermore, NR-induced mitochondrial fusion suppressed mitochondrial H2O2 and O2 center dot (-) production and reduced cardiomyocyte apoptosis in both db/db mice hearts and neonatal primary car-diomyocytes. Mechanistically, chromatin immunoprecipitation (ChIP) and luciferase reporter assay analyses revealed that PGC1 alpha and PPAR alpha interdependently regulated Mfn2 transcription by binding to its promoter region. NR treatment elevated NAD+ levels and activated SIRT1, resulting in the deacetylation of PGC1 alpha and promoting the transcription of Mfn2. These findings suggested the promotion of mitochondrial fusion via oral supplementation of NR as a potential strategy for delaying cardiac complications in patients with diabetes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据